朝聚眼科医疗控股有限公司（02219）于2025年12月31日发布翌日披露报表，公告显示当日回购80,000股普通股，约占已发行股本的0.011%。本次回购的价格范围介乎每股2.70港元至2.75港元，合计金额约218,280港元。
根据公告，公司于2025年6月6日通过股份回购授权，授权总额约70,751,050股。截至目前，公司累计回购约1,850,000股，占授权时已发行股本总数约0.26%。在本次回购完成后，公司已发行股本仍为707,510,500股，且暂无库藏股份。
公司于公告中确认，所有回购事宜均已获得董事会授权并遵守香港联交所证券上市规则及相关法律规定。公告由执行董事兼联席公司秘书张光弟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.